Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)Ended earlyNCT02196168What this trial is testingCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more National Cancer Institute (NCI) 6
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Study completedNCT00524017What this trial is testingCetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractWho this might be right forHead and Neck CancerPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00470496What this trial is testingPhotodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)WithdrawnNCT00095641What this trial is testingS0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT00003430What this trial is testingL-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsWho this might be right forHead and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific Memorial Sloan Kettering Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00117572What this trial is testingDocetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)Who this might be right forCancer of the PharynxCancer of the LarynxCancer of the Nasal Cavity+2 more University of Chicago 285
Not applicableStudy completedNCT00482872What this trial is testingGermline Mutations in Patients With Head and Neck Cancer and a Family History of CancerWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 400
Early research (Phase 1)Study completedNCT00083057What this trial is testingGefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Study completedNCT00002888What this trial is testingCombination Chemotherapy in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00978081What this trial is testingPhotodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck TumorsWho this might be right forHead and Neck CancerPrecancerous Condition Abramson Cancer Center at Penn Medicine 35
Not applicableUnknownNCT01586767What this trial is testingIntensity-Modulated or Proton Radiation Therapy for Sinonasal MalignancyWho this might be right forAdenoid Cystic CarcinomaSquamous Cell CarcinomaSinonasal Carcinoma+6 more Massachusetts General Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00058006What this trial is testingCelecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forHead and Neck CancerLung Cancer Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00503997What this trial is testingPemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 42
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00509665What this trial is testingGemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck CancerWho this might be right forHead and Neck Cancer Medical University of South Carolina 18
Not applicableStudy completedNCT01466257What this trial is testingBiomarkers in Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer ECOG-ACRIN Cancer Research Group 70